Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade

BACKGROUND: Ipilimumab is a licensed immunotherapy for metastatic melanoma patients and, in the US, as adjuvant treatment for high risk melanoma radically resected. The use of ipilimumab is associated with a typical but unpredictable pattern of side effects. The purpose of this study was to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Valpione, Sara, Pasquali, Sandro, Campana, Luca Giovanni, Piccin, Luisa, Mocellin, Simone, Pigozzo, Jacopo, Chiarion-Sileni, Vanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896157/
https://www.ncbi.nlm.nih.gov/pubmed/29642948
http://dx.doi.org/10.1186/s12967-018-1467-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896157/
https://www.ncbi.nlm.nih.gov/pubmed/29642948
http://dx.doi.org/10.1186/s12967-018-1467-x

Ejemplares similares